JPS5731614A - Lipid improver - Google Patents

Lipid improver

Info

Publication number
JPS5731614A
JPS5731614A JP10366780A JP10366780A JPS5731614A JP S5731614 A JPS5731614 A JP S5731614A JP 10366780 A JP10366780 A JP 10366780A JP 10366780 A JP10366780 A JP 10366780A JP S5731614 A JPS5731614 A JP S5731614A
Authority
JP
Japan
Prior art keywords
fatty acid
unsaturated fatty
higher unsaturated
active ingredient
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10366780A
Other languages
Japanese (ja)
Inventor
Satoshi Innami
Yoshiki Obata
Fumiko Hirahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP10366780A priority Critical patent/JPS5731614A/en
Publication of JPS5731614A publication Critical patent/JPS5731614A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: A lipid improver increasing HDL cholesterol, comprising a specific higher unsaturated fatty acid of the ω 3 type line.
CONSTITUTION: A higher unsaturated fatty acid (e.g., eicosatolienic acid, etc.) of the ω 3 type line having ≥20C is blended with a filler, weighting agent, etc. and formed into tablets, pills, powder, solution, etc., to give a lipid improver increasing HDL (high density lipoprotein) of animal body. A concentrated substance having ≥30wt%, preferably ≥50wt% of the above-mentioned higher unsaturated fatty acid and a value of peroxide (10mg equivalent/kg), slightly causing denatured products resulting from polymerization, ring formation, etc. and small smell is used as an active ingredient. A does of pharmaceutical preparation is 10W100mg/kg/day active ingredient calculated as free fatty acid and administered in divided two to four times a day.
COPYRIGHT: (C)1982,JPO&Japio
JP10366780A 1980-07-30 1980-07-30 Lipid improver Pending JPS5731614A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10366780A JPS5731614A (en) 1980-07-30 1980-07-30 Lipid improver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10366780A JPS5731614A (en) 1980-07-30 1980-07-30 Lipid improver

Publications (1)

Publication Number Publication Date
JPS5731614A true JPS5731614A (en) 1982-02-20

Family

ID=14360132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10366780A Pending JPS5731614A (en) 1980-07-30 1980-07-30 Lipid improver

Country Status (1)

Country Link
JP (1) JPS5731614A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54176641U (en) * 1978-06-02 1979-12-13
JPS551035A (en) * 1978-06-19 1980-01-07 Matsushita Electronics Corp Manufacture of cathode ray tube
EP0087864A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical composition
JPS60248610A (en) * 1984-05-23 1985-12-09 Nitsusui Seiyaku Kk Preventive and remedy for complicated diabetes
US5264478A (en) * 1991-08-21 1993-11-23 Samsung Electron Devices Co., Ltd. Filming liquid composition for color braun tubes
US5475029A (en) * 1993-07-08 1995-12-12 The Board Of Trustees Of The Leland Stanford Junior University Farnesyl compounds as cholesterol lowering agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54154533A (en) * 1978-05-26 1979-12-05 Wellcome Found Protecting and treating preparation of thrombsis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54154533A (en) * 1978-05-26 1979-12-05 Wellcome Found Protecting and treating preparation of thrombsis

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54176641U (en) * 1978-06-02 1979-12-13
JPS5924557Y2 (en) * 1978-06-02 1984-07-20 プラチナ「万」年筆株式会社 ballpoint pen
JPS551035A (en) * 1978-06-19 1980-01-07 Matsushita Electronics Corp Manufacture of cathode ray tube
EP0087864A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical composition
JPS60248610A (en) * 1984-05-23 1985-12-09 Nitsusui Seiyaku Kk Preventive and remedy for complicated diabetes
US5264478A (en) * 1991-08-21 1993-11-23 Samsung Electron Devices Co., Ltd. Filming liquid composition for color braun tubes
US5475029A (en) * 1993-07-08 1995-12-12 The Board Of Trustees Of The Leland Stanford Junior University Farnesyl compounds as cholesterol lowering agents

Similar Documents

Publication Publication Date Title
EP0460848A1 (en) Stearidonic acid and/or eicosatetraenoic acid for the treatment of inflammations
IL58697A0 (en) Analgesic pharmaceutical compositions in the form of effervescent powders comprising metoclopramide
KR970704433A (en) Use of DHA as a pharmaceutical composition (Use of DHA as a pharmaceutical composition)
KR20010108435A (en) Formulation comprising testosteron undecanoate and castor oil
IE791806L (en) Gastroprotective mollusc extract
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
AU528098B2 (en) Analgesic tablet
JPS5731614A (en) Lipid improver
JPS6429314A (en) Medicine dosage
JPS5716818A (en) Steroid fatty emulsion
ES8400028A1 (en) Waterless thixotropic composition.
GR3023074T3 (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
JPH10500937A (en) Anti-inflammatory and protective effects of sesaminic lignans
JPS6345366B2 (en)
ES8707111A1 (en) Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases
JPS5793913A (en) Enhancing agent for spermous vital power
Beck et al. I. Drug Sensitivity of Rat Adjuvant Arthritis, Induced with ‘Adjuvants’ Containing no Mineral Oil Components
JPS60218318A (en) Composition for filling in soft capsule
RU2125444C1 (en) Erythromycin-containing drug
JPS5612309A (en) Oral drug containing ubidecarenone
JPS5742623A (en) Antialcoholic adipohepatic agent
JP3051375B2 (en) Antiallergic agent containing conjugated linoleic acid as active ingredient
JPS6237602B2 (en)
JP2001064171A (en) Deconjugate protein expression inducing agent
JPS5498339A (en) Carcinostatic agent